- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
800 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
Trial Details
Key Eligibility Criteria
405 Participants Needed
Trial Details
Key Eligibility Criteria
129 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
68 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
Trial Details
Key Eligibility Criteria
31 Participants Needed
Trial Details
Key Eligibility Criteria
192 Participants Needed
Trial Details
Key Eligibility Criteria
224 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
Trial Details
Key Eligibility Criteria
216 Participants Needed
Trial Details
Key Eligibility Criteria
160 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
82 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
Trial Details
Key Eligibility Criteria
196 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
108 Participants Needed
"I am an active athlete who is not ready or willing to stop my activities because of knee pain at 42. I have tried cortisone shots and found they only temporary mask the issue, or even cause more problems later. That's why I started researching medical studies."
"I’ve tried several meds without too much relief. Injections only work on my right knee but not much on the left knee. My pain is nearly unbearable at this point. Hoping to learn about what promising drugs exist in trials."
"I have been struggling with severe knee pain since my service in the military. I am only 52! I miss doing the things I used to do."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've been 17+ years in pain with bilateral osteoarthritis. PRP and HA injections have not helped. Physical therapy has helped only to a certain degree. I'm looking for new treatment options before considering replacement. "
Trial Details
Key Eligibility Criteria
510 Participants Needed
Trial Details
Key Eligibility Criteria
80 Participants Needed
Trial Details
Key Eligibility Criteria
67 Participants Needed
Trial Details
Key Eligibility Criteria
72 Participants Needed
Trial Details
Key Eligibility Criteria
540 Participants Needed
Trial Details
Key Eligibility Criteria
474 Participants Needed
Trial Details
Key Eligibility Criteria
43 Participants Needed
Trial Details
Key Eligibility Criteria
140 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
135 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Osteoarthritis trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Osteoarthritis is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added SL1002 for Osteoarthritis, Methylprednisolone for Knee Arthritis and Knee Braces for Osteoarthritis to the Power online platform.